Arizona State Retirement System’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Arizona State Retirement System’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,852	Closed	-$380K	–	2312
2021 Q3	$380K	Buy	18,852 +493	+3%	+$13.6K	﹤0.01%	1696
2021 Q2	$685K	Sell	18,359 -210	-1%	-$6.44K	0.01%	1380
2021 Q1	$475K	Buy	18,569 +215	+1%	+$5.49K	﹤0.01%	1572
2020 Q4	$404K	Sell	18,354 -603	-3%	-$13.3K	﹤0.01%	1576
2020 Q3	$341K	Buy	18,957 +4,808	+34%	+$99.6K	﹤0.01%	1529
2020 Q2	$359K	Buy	14,149 +2,100	+17%	+$45.2K	0.01%	1316
2020 Q1	$221K	Buy	+12,049	New	+$234K	﹤0.01%	1466

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Arizona State Retirement System's DRNA Position: Q4 2021 in Review

Arizona State Retirement System sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 18,852 shares — an estimated $380K sold.

Arizona State Retirement System first reported a position in DRNA in Q1 2020 and held it in 7 quarters. The position peaked at $685K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Arizona State Retirement System reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Arizona State Retirement System sold 18,852 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $380K.
Arizona State Retirement System first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2020 and held it in 7 quarters.
Arizona State Retirement System's Dicerna Pharmaceuticals, Inc. position peaked at $685K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Arizona State Retirement System's 13F filing for Q4 2021, filed 4 Feb 2022.